| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/09/2008 | US20080249077 glucocorticoid receptor agonists; to treat inflammatory and allergic conditions; Fluoromethyl(6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate |
| 10/09/2008 | US20080249076 slow release over an extended period of time and markedly increased bioavailability; significantly reduces food effect and may reduce side effects; dissolved in a solid vehicle or carrier and is especially suitable for oral solid dosage forms |
| 10/09/2008 | US20080249075 C11 Modified Retrosteroids as Progesterone Receptor Modulator Compounds |
| 10/09/2008 | US20080249074 Composition for the Transdermal Administration of Physiologically Active Agents |
| 10/09/2008 | US20080249073 Skin Treatment Composition |
| 10/09/2008 | US20080249072 Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators |
| 10/09/2008 | US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide |
| 10/09/2008 | US20080249070 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol |
| 10/09/2008 | US20080249069 Method of treatment using bisphosphonic acid |
| 10/09/2008 | US20080249068 Administering an appropriate dosage schedule of a bone calcium resorption inhibitor like alendronate and a toxic dose of a vitamin D compounds like 1, alpha 25-dihydroxyvitamin D3 without developing hypercalcemia |
| 10/09/2008 | US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 10/09/2008 | US20080249066 Antiviral compounds and compositions |
| 10/09/2008 | US20080249065 glycine and proline; to treat a corneal ulceration; promote corneal re-epithelialisation and rapid healing; treatment of dry eye |
| 10/09/2008 | US20080249064 plant extract polygalactomannans for use in cosmetic, treating aging of the skin, anti-wrinkle and smoothing properties |
| 10/09/2008 | US20080249063 Composition for promoting the maintenance and function of muscle-specific progenitor cells |
| 10/09/2008 | US20080249062 gel-like composition for use in a deformed intervertebral disc; comprising a crosslinked chondroitin sulfate; improvement of pain (backache) over a long period of time |
| 10/09/2008 | US20080249061 Photostable Pharmaceutical Composition Containing Brivudine for the Treatment of Herpetic Keratitis |
| 10/09/2008 | US20080249060 Nucleoside derivatives for treating hepatitis c virus infection |
| 10/09/2008 | US20080249059 contacting islet cell with an agent that increases intracellular levels of 0-acetyl-ADP-ribose, resulting in cellular depolarization and/or Ca2+ entry which modulates insulin secretion; puromycin; agent which inhibits sirtuin activity thereby preventing islet cell death; nicotinamide |
| 10/09/2008 | US20080249058 Agents that reduce neuronal overexcitation |
| 10/09/2008 | US20080249057 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 10/09/2008 | US20080249056 agents that affect the activity and/or expression of CXCL16 can be used to alter the uptake of D-type CpG oligodeoxynucleotides; to decrease an immune response; antagonist of ADAM-10 is GW280264X, G1254023X or GM6001 |
| 10/09/2008 | US20080249055 Use of Seh Inhibitors as Analgesics |
| 10/09/2008 | US20080249054 using a PAT family protein to screen agents for the ability to regulate lipid metabolism; obesity, diabetes [non-insulin and insulin dependent], hypertension, coronary artery disease, hyperlipidemia, hypolipidemia, lipid metabolism disorders, lipid deposition disorders, lipodystrophies |
| 10/09/2008 | US20080249053 Compositions And Methods For Detecting And Treating Neurological Conditions |
| 10/09/2008 | US20080249052 Synthetic mini/micro-dystrophin genes to restore nNOS to the sarcolemma |
| 10/09/2008 | US20080249051 compounds that modulate the shikimate pathway and/or a pathway branching from the shikimate pathway in members of the Amoebida Order |
| 10/09/2008 | US20080249050 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 10/09/2008 | US20080249048 such as IBD and Crohn's disease; intrarectal administration of siNA compounds |
| 10/09/2008 | US20080249046 MODIFIED siRNA MOLECULES AND USES THEREOF |
| 10/09/2008 | US20080249045 MGAL: A GAL Gene Switch-Based Suite of Methods for Protein Analyses and Protein Expression in Multicellular Organisms and Cells Therefrom |
| 10/09/2008 | US20080249044 Nucleic acid external skin formulation |
| 10/09/2008 | US20080249043 Methods and Compositions Involving Protein Kinase C-Delta |
| 10/09/2008 | US20080249042 cultured prokaryotic or eukaryotic cell transformed or transfected with expression construct; vectors; treating retinal disease or blindness |
| 10/09/2008 | US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 10/09/2008 | US20080249040 Molecules having sense and antisense strands; metabolic and cardiovascular disorders; in vivo stability and activity |
| 10/09/2008 | US20080249039 Modified Short Interfering Rna (Modified Sirna) |
| 10/09/2008 | US20080249038 Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof |
| 10/09/2008 | US20080249037 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus |
| 10/09/2008 | US20080249036 Antagonist Against Tolerance to Anticancer Drugs |
| 10/09/2008 | US20080249035 exhibits a characteristic X-ray diffraction pattern; dissolving clarithromycin in a ketone; precipitation is carried out by cooling |
| 10/09/2008 | US20080249034 For both the treatment of inflammatory bowel diseases and the prevention of colon cancer; O5-[3-oxoethyl)-methylamino- beta -D-xylo-3,4,6-trideoxy-hexapyranosyl]-9-hydroxy-9-deoxo-erythronolide-A; side effect reduction |
| 10/09/2008 | US20080249033 Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections |
| 10/09/2008 | US20080249032 Derivatives of Arylsulfonamido-Substituted Hydroxamic Acid as Matrix Metalloproteinases Inhibitors |
| 10/09/2008 | US20080249030 Age Inhibitors |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080249003 Compounds Inhibiting the Binding of Sap for Treating Osteoarthritis |
| 10/09/2008 | US20080249001 Agents that alleviate side-effects caused by chemotherapy agents |
| 10/09/2008 | US20080248998 Glyceryl stearate or glyceryl palmitostearate to mask bad flavor of drugs; anti-bacterial, antifungal, metronidazole, anti-parasitic, nivaquine, antiviral, anti-cancer, analgesics, non-steroidal anti-inflammatories, anti-tussives, psychotropic, steroids, anti-histamines, anti-allergic agents |
| 10/09/2008 | US20080248994 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration |
| 10/09/2008 | US20080248991 Chitosan Containing Solution |
| 10/09/2008 | US20080248955 Emulsifiable Concentrates Containing Adjuvants |
| 10/09/2008 | US20080248571 Method of Production of Artificial Skin |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248553 Recombinant food-grade microorganism for use as bioreactor in production of monoglutamyl folate |
| 10/09/2008 | US20080248139 adding an effective amount of p-pivaloyloxyferutinine to an acceptable excipient for a cosmetic or dermatological composition |
| 10/09/2008 | US20080248134 antiproliferative agents for inducing p53 expression and decreasing survivin expression in cells; multidrug resistant proliferative disorders; synergistic use with other chemotherapeutic agents like temozolomide |
| 10/09/2008 | US20080248133 Compositions and methods for nutrition supplementation |
| 10/09/2008 | US20080248132 Compositions and methods for nutrition supplementation |
| 10/09/2008 | US20080248131 Protein Kinase Modulation by Hops and Acacia Products |
| 10/09/2008 | US20080248130 Composition and Method For the Promotion of Hair Growth on a mammal |
| 10/09/2008 | US20080248129 Compounds and methods for promoting cellular health and treatment of cancer |
| 10/09/2008 | US20080248126 preparation of drug-polymer (or oligomer) conjugates; nanoprecipitation |
| 10/09/2008 | US20080248124 Process for producing pharmaceutical composition |
| 10/09/2008 | US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer |
| 10/09/2008 | US20080248121 Multiple emulsion containing a tensioning agent |
| 10/09/2008 | US20080248119 Production method of drug containing composite particle |
| 10/09/2008 | US20080248118 Antioxidant superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase hemeoxygenase, acetyl salicyclic acid, mannitol, captopril, Arg, or pyruvate; vitamins(lycopene, lutein, xeaxanthine, Vitamin A, carotene); administered via carotid artery or juguar vein |
| 10/09/2008 | US20080248115 Combinations of statins and anti-obesity agent |
| 10/09/2008 | US20080248114 an improved 16-hour cumulative dissolution of dihydropyridine drug such as isradipine; a drug layer, an osmotic layer, and an outer coating includes an opening, surrounding the drug layer and osmotic layer; dosage form (tablets); 2% N,N-dimethyl dodecylamine N-oxide (LDAO) or equivalent solvent |
| 10/09/2008 | US20080248112 Use of ranolazine for the treatment of coronary microvascular diseases |
| 10/09/2008 | US20080248110 Pharmaceutical Compositions Useful in the Treatment of Pain |
| 10/09/2008 | US20080248109 succinic acid particles or any salts and (ii) hydroxypropyl methyl cellulose phthalate an enteric-coated proton pump inhibitor (PPI) omeprazole; succinic acid particles are released in the stomach in an amount sufficient to reduce gastric acid secretion in conjunction with the PPI; sustained release |
| 10/09/2008 | US20080248107 Controlled Release Formulation |
| 10/09/2008 | US20080248106 Melatonin-based composition for improved sleep |
| 10/09/2008 | US20080248105 Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| 10/09/2008 | US20080248103 Melatonin-based composition for improved sleep |
| 10/09/2008 | US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/09/2008 | US20080248100 Magnesium compositions and uses thereof |
| 10/09/2008 | US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide |
| 10/09/2008 | US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications |
| 10/09/2008 | US20080248097 Polymeric micelles for combination drug delivery |
| 10/09/2008 | US20080248096 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 10/09/2008 | US20080248095 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 10/09/2008 | US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol |
| 10/09/2008 | US20080248092 Formulations of Water Insoluble or Poorly Water Soluble Drugs in Lipidated Glycosaminoglycan Particles and Their Use for Diagnostic and Therapy |
| 10/09/2008 | US20080248089 wasabi extract of 4-pentenyl isothiocyanate, 5-hexenyl isothiocyanate, 3-butenyl isothiocyanate, 3-methylthiopropyl isothiocyanate; delivered by chewing gum, confectionary product; sensate, potentiator; oral care agents, antibacterial activities, promotion of saliva secretion |
| 10/09/2008 | US20080248084 Method of treating acute dysfunction of cardiac muscle |
| 10/09/2008 | US20080248082 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 10/09/2008 | US20080248081 Method of treating chronic dysfunction of cardiac muscle |
| 10/09/2008 | US20080248077 Anastrozole continuously released from polylactide or poly(lactide-co-glycolide) co-polymer implant over 10 day period in aqueous physiological environment; drug incorporated in microparticle formulations and monolithic implant formulations; breast cancer |
| 10/09/2008 | US20080248070 pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent |
| 10/09/2008 | US20080248069 Dosage Forms of Active Ingredients Containing Hydroxystilbene for Treating Menopausal Complaints |
| 10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
| 10/09/2008 | US20080248055 Using glutamate decarboxylase therapeutic for treatment and prevention of pancreatic disorders |
| 10/09/2008 | US20080248049 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy |
| 10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
| 10/09/2008 | US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders |
| 10/09/2008 | US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders |